Jasmine Sra
Internal Medicine · Glendale, AZNPI 1689006785
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $533 and has fallen 61.3% since, to $206 in 2025.
Across 106 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$429
- Novo Nordisk$283
- AbbVie$208
- Lilly USA, LLC$149
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$147
- Abbott$136
- plus $698 from 21 others
What the payments were for
- Food & beverage$2,03799%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $429 |
| Novo Nordisk | 18 | $283 |
| AbbVie(2 entities) | 12 | $208 |
| Lilly USA, LLC | 9 | $149 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $147 |
| Abbott | 7 | $136 |
| Amgen | 1 | $92 |
| GSK | 5 | $86 |
| Sanofi-aventis U.S. LLC | 4 | $70 |
| Boston Scientific | 2 | $57 |
| Clarus Therapeutics Inc. | 3 | $47 |
| Bayer | 3 | $45 |
| Saluda Medical Americas, Inc. | 1 | $41 |
| Daiichi Sankyo Inc. | 2 | $28 |
| Progenics Pharmaceuticals, Inc. | 1 | $25 |
| Pfizer | 1 | $25 |
| Redhill Biopharma Inc. | 1 | $24 |
| Antares Pharma, Inc. | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Intuitive Surgical | 1 | $16 |
| Nevro Corp. | 1 | $14 |
| Medtronic | 1 | $14 |
| Merck | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,050 in reported general payments places this provider in the 85th percentile of 2,212 internal medicine providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 16 | $457 |
| Atorvastatin Calcium | 29 | $160 |
| Levothyroxine Sodium | 17 | $134 |
| Losartan Potassium | 11 | $131 |
| Metformin Hcl | 12 | $121 |
| Amlodipine Besylate | 15 | $86 |
| Lisinopril | 17 | $80 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Glendale
- Christine HarterGlendale$127K
- George AvilesGlendale$18K
- Michael CastroGlendale$16K
- Bindu RajanGlendale$16K
- Frank LovecchioPhoenix$911K
- Nasser HajaigPhoenix$687K
- Rajesh JanardhananTucson$685K
- Mona SelejTucson$440K
- Kelly KrohnPhoenix$262K
- Jacque SokolovScottsdale$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.